| Product Name | Hederagenin |
|---|---|
| CAS | 465-99-6 |
| Formula | C30H48O4 |
| MW | 472.70 |
| Appearance | 白色粉末 |
| Melting point | 325 °C |
| Boiling point | 589.4±50.0 °C | Condition: Press: 760 Torr |
| PKa | 4.63±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Hederagenin |
|---|---|
| CAS | 465-99-6 |
| Formula | C30H48O4 |
| MW | 472.70 |
| Appearance | 白色粉末 |
| Melting point | 325 °C |
| Boiling point | 589.4±50.0 °C | Condition: Press: 760 Torr |
| PKa | 4.63±0.70 | Condition: Most Acidic Temp: 25 °C |
| Extracellular Vesicle Delivery of Neferine for the Attenuation of Neurodegenerative Disease Proteins and Motor Deficit in an Alzheimer’s Disease Mouse Model | ||
| Source:SCI：Pharmaceuticals | Author:Bin Tang | Notes：影響因子：5.863 |
| Reference description | ||
The exosome-encapsulated compounds (Exo-Bai, Exo-Hed, Exo-Nef, Exo-Rg3, Exo-Rapa and Exo-Rb1) were prepared by the RT method, as described [22]. In brief, 100 μg Bai, Hed, Nef, Rg3 and Rb1 (purchased from Sichuan Weikeqi Biological Technology Co., Ltd., Sichuan, China) or Rapa (purchased from Guangzhou Tomums Life Science Co., Ltd., Guangdong, China) were incubated with exosomes (25 μg) in a ratio of 4:1 in PBS at 22 °C for 18 h before being subjected to quantitation. | ||
